Anaphylaxis after application of topical bacitracin-neomycin powder.
SC Allergy and Clinical Immunology, AOU Città della Salute e della Scienza di Torino, Molinette Hospital, Turin, Italy. Electronic address: luisa.bommarito@gmail.com.
Luisa
L
Bommarito
SC Allergy and Clinical Immunology, AOU Città della Salute e della Scienza di Torino, Molinette Hospital, Turin, Italy.
Sabrina
S
Mietta
SC Allergy and Clinical Immunology, AOU Città della Salute e della Scienza di Torino, Molinette Hospital, Turin, Italy.
Gianni
G
Cadario
D000279:Administration, Cutaneous; D000707:Anaphylaxis / Q000139:chemically induced* / Q000628:therapy; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001414:Bacitracin / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D004338:Drug Combinations; D004342:Drug Hypersensitivity / Q000209:etiology* / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009355:Neomycin / Q000008:administration & dosage / Q000009:adverse effects*; D010328:Patch Tests; D014034:Toes / Q000293:injuries; D014946:Wound Infection / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D001414:Bacitracin; D009355:Neomycin